Arnaud J. Legrand
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
PARP-1 Inhibition Increases Oxidative Stress in Ets-1-Expressing MDA-MB-231 Breast Cancer Cells.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 29, 2024
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.
Journal: Nature communications
Published: March 18, 2024
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity.
Journal: Nature reviews. Cancer
Published: January 26, 2024
Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours.
Journal: International journal of molecular sciences
Published: July 16, 2023
The NUCKS1-SKP2-p21/p27 axis controls S phase entry.
Journal: Nature communications
Published: April 08, 2020
The Diversification of Cell Death and Immunity: Memento Mori.
Journal: Molecular cell
Published: July 12, 2019
Ets-1 interacts through a similar binding interface with Ku70 and Poly (ADP-Ribose) Polymerase-1.
Journal: Bioscience, biotechnology, and biochemistry
Published: June 19, 2018
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: June 08, 2018
Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts.
Journal: Oncotarget
Published: October 11, 2017
Last Updated: 09/26/2026